Dubin Glenn
SEC CIK 1308597 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | Dir | 22.1K | — | — | 12 | 2021-07-02 | 2024-04-01 |
Most active insiders at CCCC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | REYNO LEONARD | Chief Medical Off | — | $22.2K |
| 2 | Mahaney Paige | CSO | — | — |
| 3 | Mossler Mark | CAO | — | — |
| 4 | Adams Kendra | CFO | — | — |
| 5 | Boyle Scott N | Chief Business Off | — | — |
| 6 | Anderson Kenneth Carl | Dir | — | — |
| 7 | Schick Kelly | CHRO | — | — |
| 8 | GROGAN DONNA ROY | Dir | — | — |
| 9 | Hirsch Andrew | Pres, CEO, Dir | — | — |
Dubin Glenn made no open-market trades at CCCC in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-02 | 2024-04-01 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $8.10 | +1,358 | 22.1K | +7% | +$11.0K | |
| 2024-01-03 | 2024-01-02 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $6.52 | +1,687 | 20.7K | +9% | +$11.0K | |
| 2023-10-03 | 2023-10-02 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $1.70 | +6,470 | 19.0K | +52% | +$11.0K | |
| 2023-07-05 | 2023-07-03 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $2.83 | +3,887 | 12.6K | +45% | +$11.0K | |
| 2023-04-04 | 2023-04-03 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $3.20 | +3,438 | 8,673 | +66% | +$11.0K | |
| 2023-01-04 | 2023-01-03 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $6.38 | +1,725 | 5,235 | +49% | +$11.0K | |
| 2022-10-04 | 2022-10-03 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $8.69 | +1,265 | 3,510 | +56% | +$11.0K | |
| 2022-07-05 | 2022-07-01 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $8.03 | +1,372 | 2,245 | +157% | +$11.0K | |
| 2022-04-05 | 2022-04-04 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $26.46 | +379 | 873 | +77% | +$10.0K | |
| 2022-01-18 | 2022-01-04 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $31.58 | +199 | 494 | +67% | +$6,284 | |
| 2021-10-05 | 2021-10-04 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $44.99 | +138 | 295 | +88% | +$6,209 | |
| 2021-08-20 | 2021-07-02 | CCCC | C4 Therapeutics, Inc. | Dubin Glenn | Dir | A - Grant | $39.72 | +157 | 157 | New | +$6,236 |
Purchase Sale Sale after option exercise All abbreviations